Natco Pharma, in partnership with Breckenridge Pharmaceutical, Inc., has announced the launch of Pomalidomide capsules in the United States, marking a significant expansion of its oncology and specialty portfolio in the world’s largest pharmaceutical market. The product is a generic version of Pomalyst, originally marketed by Celgene. Pomalidomide capsules are available in 1 mg, 2 […]